Skip to content

Biological Changes in the Adipose Tissue Among Pregnant Women With Diabetes

Biological Changes in the Adipose Tissue (RNA Profile) Among Pregnant Women With Diabetes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02383537
Enrollment
150
Registered
2015-03-09
Start date
2017-04-30
Completion date
2020-02-29
Last updated
2016-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Pregnancy

Brief summary

The aim of the research is to study the effect of miRNA, fat tissue and insulin resistance on the pathophysiology of diabetes during pregnancy. During the study fat tissue, Umbilical cord blood, placenta tissue and subcutaneous fat will be taken from pregnant diabetic woman over going a C-section. Healthy pregnant women will serve as a control group.

Detailed description

The aim of the research is to study the effect of miRNA, fat tissue and insulin resistance on the pathophysiology of diabetes during pregnancy. During the study: 1. fat tissue, Umbilical cord blood, placenta tissue and subcutaneous fat will be taken from pregnant diabetic woman over going a C-section. 2. Bloods will be analyzed for insulin, c-peptide, glucose and fat profile 3. Placenta and fat tissue will be analyzed for miRNA and total RNA 4. Clinical and anthropometric measurements will be taken from the mother 5. Placenta status will be taken

Interventions

OTHERDiabetes

the trial is observational with no intervention

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-45 * pregnant * signed consent form * going through an elective C-section * Diabetic * reference group: healthy women with no background illness

Exclusion criteria

* \<18 or \>45 * chronic illness that may effect the outcome * polypharmacy

Design outcomes

Primary

MeasureTime frame
miRNA profilingsamles are taken during C-section samples will be analyzed after completion of collection

Contacts

Primary ContactUriel Elchalal, Proffessor
Uriel@hadassah.org.il+972-2-6776424

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026